Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 September 2020 | Story Leonie Bolleurs | Photo Supplied
With the research grant awarded to Dr Thulisile Mphambukeli, she has the opportunity to make a difference in society, especially in terms of the incorporation of social justice into planning.

The Joint National Institute for the Humanities and Social Sciences (NIHSS) and Chinese Academy of Social Sciences (CASS) research projects have awarded a R500 000 research grant to a team led by Dr Thulisile Mphambukeli, the principal investigator (PI). 

Within the parameters of the theme of social justice, sustainable development, and quality of life, Dr Mphambukeli’s team will focus their research on exploring the land policies in BRICS that inform agricultural practices. They will also document the policy approaches and strategies adopted by China and South Africa respectively to support the agriculture-land-water-labour nexus; additionally, they will propose a common agricultural land policy for China and South Africa. 

The title of the research project is: Exploring the Situated Political Ecology and Economy of Agricultural Land Policies in BRICS: A Case Study of China and South Africa. 

Dr Mphambukeli, who is passionate about social justice, is a Senior Lecturer in the Department of Urban and Regional Planning at the University of the Free State (UFS). With this project, she has the opportunity to make a difference in society, especially in terms of social justice. 

 

We don’t want to see the next generation suffer because we did not use our voice.- Dr Thulisile Mphambukeli

The human factor is crucial

“We need to understand the dynamics of local communities. The incorporation of social justice in planning is crucial! We cannot claim that we ‘plan for people’ and ignore them at the same time. People must be at the centre of what we do. No one must be deprived of their fundamental basic human rights.”

The team consists of Dr Mphambukeli (PI), Prof Peliwe Lolwana (University of the Witwatersrand), Dr Victor Okorie (Enugu State University of Science and Technology, Nigeria), and Dr Abraham Matamanda (UFS).

For this initiative, the China Africa Institute (CAI), which is part of CASS, joined hands with the NIHSS. Together, they will oversee the research projects of researchers and academics from South Africa and China. The research project, running from 1 April this year to 31 March 2021, will bring forth publications/research outputs, advocacy policy briefs, and proceeding reports.

The programme aims to strengthen research in the field of the humanities and social sciences between the two countries. 

Support the fight against climate change

She believes that although the BRICS countries are not geographically connected, it is a functional community with the same interests. “As BRICS countries, we need to cooperate in the fight against climate change. It affects so many components, including water, food, agriculture, land, and quality of infrastructure,” says Dr Mphambukeli. 

Due to the current COVID-19 pandemic, researchers will meet online to discuss how China and South Africa can collaborate and cooperate. “We don’t want to see the next generation suffer because we did not use our voice,” she says. 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept